Articles tagged with Gastroenterology
The American Gastroenterological Association has released a new clinical decision tool to guide gastroenterologists in assessing and treating patients with Crohn's disease. The tool synthesizes current literature to create a practical algorithm for clinicians, providing a pathway for better quality care.
A retrospective single-center study found that restarting infliximab therapy after a drug holiday is safe and effective for IBD patients. The average duration of infliximab holiday was 15 months. Patients who were in remission at the time infliximab was discontinued showed a 78 percent response rate at one year.
A subset of stage III colon cancer patients with CpG island methylator phenotype (CIMP) showed improved overall survival when treated with irinotecan-based therapy. Patients with CIMP-negative tumors experienced significant harm from the addition of irinotecan, resulting in lower overall survival rates.
Fecal microbiota transplantation (FMT) shows promise in treating a broad range of gastrointestinal disorders, including irritable bowel syndrome and inflammatory bowel disease. A new orally delivered community of microbes has been developed to address the challenges of FMT.
The American Gastroenterological Association has awarded seven high school students with grants to support their research projects on digestive diseases. The students will receive up to $2,500 each to conduct research for at least 10 weeks.
A new study published in Clinical Gastroenterology and Hepatology found that thiopurine therapy for inflammatory bowel disease (IBD) may increase the risk of myeloid disorders, including acute myeloid leukemia. The study analyzed data from over 19,000 IBD patients and found a seven-fold increased risk among those taking thiopurines.
The US Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed colorectal cancer patients with a familial risk of the disease. Genetic testing can confirm the diagnosis of Lynch syndrome and direct management for affected individuals, as well as family members.
Gastroenterology and Clinical Gastroenterology and Hepatology journals received record-high impact factors, with Gastroenterology having the highest at 13.9. The journals' commitment to disseminating top clinical research is recognized by the GI community.
A new study finds that statin use significantly reduces the risk of developing Barrett's esophagus, with the greatest effect seen in obese patients. Those with a body mass index greater than or equal to 30 had a 74 percent reduction in Barrett's esophagus odds.
A new study found that dietary elimination therapy is an effective treatment for adults with eosinophilic esophagitis, with 71 percent of patients experiencing symptom improvement. The most common triggers were dairy and eggs, and adding them back to the diet after a six-week period showed promising results.
The ESPGHAN statement provides practical guidance on PEG tube placement and care, emphasizing the safety and effectiveness of this procedure for children with feeding and nutrition problems. The decision to insert a PEG tube should be made by a team experienced in carrying out the procedure.
A toolbox has been created to assist gastroenterology training directors in meeting ACGME Internal Medicine Subspecialty Reporting Milestones requirements. The toolkit includes 13 core tasks, or entrustable professional activities, that define the work of gastroenterologists and hepatologists.
Two studies published in Gastroenterology found that antiviral therapy can reduce the risk of liver cancer in patients with chronic hepatitis B infection. Younger patients with minimal liver damage and those treated with nucleos(t)ide analogues showed a significant reduction in liver cancer risk.
A growing number of colorectal cancer deaths in Europe necessitates an increase in nurse endoscopy training, with regular screening reducing the risk by 20-30%. UEG and ESGENA are working together to standardize training requirements and improve workforce availability.
A new phase 2 study found that the enzyme ALV003 reduces gluten-induced injury to the small intestine, decreasing gastrointestinal symptoms in celiac disease patients. The treatment was well-tolerated and appeared to be effective in reducing damage caused by low levels of gluten.
A new study published in Clinical Gastroenterology and Hepatology found that probiotics can modify the gut microbiota to prevent hepatic encephalopathy in patients with cirrhosis of the liver. The researchers discovered that probiotic supplementation was not associated with any side effects, suggesting a safer treatment option.
The AGA Institute published a special issue on the intestinal microbiome, exploring its role in maintaining human health and developing certain diseases. The research focuses on basic concepts, gut microbiome and disease interactions, and modification of the microbiome to maintain health or treat disease.
The American Gastroenterological Association has awarded several distinguished individuals for their lifetime contributions to the field of gastroenterology. Nicholas F. LaRusso, MD, AGAF, received the Julius Friedenwald Medal, while John A. Williams, MD, PhD, was honored with the Distinguished Achievement Award for his major research ...
A pilot study found that a vibrating capsule increased spontaneous bowel movements and decreased constipation symptoms in patients with chronic idiopathic constipation (CIC) and C-IBS. The capsule uses mechanical stimulation to mimic the body's natural physiology, avoiding common side effects of medication.
At DDW 2014, researchers presented cutting-edge data on inflammatory bowel disease (IBD) therapies and the impact of the gut microbiome on digestive health. The AGA Institute showcased its latest advances in GI research, including new treatments for pancreatic cancer and colorectal polyps.
The American Gastroenterological Association has awarded fellowships to 10 minority college students to further their research careers in digestive disease and nutrition. The 2014 AGA Investing in the Future Student Research Fellowship Award recipients will conduct eight to 10 weeks of research related to digestive diseases or nutrition.
The American College of Physicians has launched a High Value Care Coordination Toolkit to improve communication between primary care doctors and gastroenterologists. The toolkit includes data sets and guidelines for referrals, aiming to reduce unnecessary tests and delays in care.
The American Gastroenterological Association has developed a framework for a colonoscopy bundled payment model, which provides a structure for physicians and facilities to negotiate payment. The model includes services and supplies provided before, during, and after the procedure, aiming to improve quality and value of care.
Researchers at Mayo Clinic have discovered a specific genetic defect in the SCN5A gene that causes disruption in bowel function, leading to irritable bowel syndrome. This breakthrough finding has given researchers hope of developing disease-modifying agents to treat IBS.
A University at Buffalo study found that IBS patients' health perceptions are more closely tied to non-biomedical factors such as social relationships and fatigue than the severity of their gastrointestinal symptoms. The study, which included 234 IBS patients, suggests that addressing these underlying issues could lead to improved clin...
IBS patients exhibit imbalanced gut microbiota composition and altered digestive functions. A low-fiber diet rich in FODMAPs can exacerbate symptoms, while a balanced Western diet with low FODMAP content may improve IBS symptoms.
A healthy diet rich in vegetables, salads, and fruits, as well as fermented dairy products containing probiotics, can help maintain digestive health. Probiotics also have beneficial effects at all stages of life, including the very early ones, supporting disease prevention and treatment in children and immunocompromised individuals.
The American Gastroenterological Association highlights significant new colorectal cancer (CRC) research in Clinical Gastroenterology and Hepatology and Gastroenterology. Studies reveal the impact of patient factors on colonoscopy preparation quality, as well as the relationship between dietary fiber intake and reduced CRC risk.
The REACT clinical trial found that an accelerated step-care approach can improve the management of Crohn's disease by inducing remission, reducing corticosteroid use, and healing intestinal ulcers. This new strategy involves early introduction of combined immunosuppression in high-risk patients.
Early use of biologic drugs in children with moderate to severe Crohn's disease achieves higher clinical remission rates and normal growth velocity compared to standard treatment. Researchers found that anti-TNF-α therapy is more effective at achieving remission than immunomodulatory drugs.
The new guidelines recommend using anti-TNF-α biologic agents to induce remission in patients with moderately severe Crohn's disease. The guidelines also provide recommendations for maintenance of remission, including the use of thiopurines or anti-TNF-α drugs.
Recent studies published in Clinical Gastroenterology and Hepatology investigate the association between diverticulosis, constipation, vitamin D levels, and risk of acute diverticulitis. The research provides new perspectives on the condition, challenging common beliefs and offering potential therapeutic strategies.
Researchers found that the risk of developing diverticulitis from diverticulosis is significantly lower than previously thought, with only 1% over seven years. Younger patients diagnosed with diverticulosis are more likely to progress to diverticulitis.
A study published in Medical Care found that high-volume ERCP providers had lower failure rates and hospitalization rates compared to low-volume providers. The authors suggest establishing quality improvement guidelines and credentialing processes to improve patient outcomes.
The American Gastroenterological Association has expanded its corporate grant with Covidien to advance gastroenterology research and improve patient outcomes. The AGA-Covidien Research and Development Pilot Award in Technology will provide funding for innovative devices, diagnostic tools, and technologies.
The AGA Clinical Decision Tool for the Screening and Evaluation of Hepatitis C will aid gastroenterologists in managing HCV-positive patients. The tool provides an evidence-based approach to initial evaluation of HCV-positive patients, helping to address the growing burden of chronic HCV infection.
A new study published in Gastroenterology found that high-calorie diets, regardless of sugar type, contribute to the development of nonalcoholic fatty liver disease. The study revealed comparable effects of fructose and glucose on the liver, highlighting calorie intake as a key factor in liver disease progression.
A meta-analysis of 16 high-quality studies found that coffee consumption reduces the risk of hepatocellular carcinoma (HCC) by about 40%, with 3 cups per day showing a 50% reduction. Chronic infections with hepatitis B and C viruses are the main causes of liver cancer.
A new study found that danoprevir added to the current treatment regimen for patients with hepatitis C leads to high rates of remission and a well-tolerated safety profile. The drug demonstrated an 85% sustained virologic response rate, making it a potential breakthrough in treating this serious liver disease.
PENTAX Medical will provide substantial funding over three years to stimulate innovation in gastroenterology, advancing science and practice. The partnership supports the AGA Institute's development of essential programming to promote innovation and technology in digestive diseases.
A systematic review and meta-analysis found that radiofrequency ablation is a safe and effective treatment for most patients with dysplastic Barrett's esophagus. The procedure led to complete eradication of dysplasia in 91% of patients, while intestinal metaplasia was eradicated in 78%, and recurrent metaplasia occurred in 13%.
A 22-year study of 88,902 participants found that colonoscopy reduced death from colorectal cancer by up to 40% compared to sigmoidoscopy. The study suggests that colonoscopy is the most effective screening method for preventing colorectal cancer.
A study published in Gastroenterology found that carbonation can trick the brain into perceiving artificially sweetened drinks as just as sweet as regular ones. This effect may facilitate weight loss by making low-calorie drinks more palatable, but it also increases sugar and food consumption.
Boston Scientific will provide a $600,000 unrestricted grant over three years to the American Gastroenterological Association (AGA) Research and Technology Initiative. This funding will support research in technology, innovation, and education in gastroenterology and hepatology.
A new study suggests a hybrid screening strategy that combines annual or biennial fecal immunological tests with a single colonoscopy at age 66 may reduce colorectal cancer incidence and mortality while lowering costs. This approach can deliver health benefits comparable to current strategies, making it an attractive alternative.
A new study published in Clinical Gastroenterology and Hepatology found that probiotic Saccharomuces boulardii does not prevent clinical relapse in patients with Crohn's disease. The one-year follow-up period showed similar rates of relapse between patients treated with S. boulardii or placebo.
A Phase 2 study found eluxadoline to be effective in decreasing abdominal pain and improving stool consistency without significant constipation risk. Symptom relief and quality of life scores increased over time, suggesting potential for a safe and effective treatment option.
Teduglutide improves intestinal absorption, reducing parenteral nutrition dependency and IV-fluid requirements. Patients with short-bowel syndrome experience significant relief from debilitating symptoms, achieving enhanced quality of life.
A new study published in Gastroenterology reveals a significant increase in drug-induced liver injury cases worldwide. The most common culprits were antibiotics like amoxicillin-clavulante, immunosuppressants such as azathioprine and biologics like infliximab.
A study at MassGeneral Hospital found significant disparities in the use of specialty services among African-American and Hispanic children with autism. Minority children were less likely to receive subspecialty care or procedures related to gastrointestinal issues, anxiety, or sleep disorders.
The AGA Research Foundation and Horizon Pharma awarded fellow and student abstract prizes to outstanding young researchers presenting at Digestive Disease Week. This year's winners include Jana G. Al Hashash, James D. Canavan, and Anne E. Powell, who received $1,000 awards each.
A new study found that screening only high-risk patients for celiac disease is more cost-effective than universal screening, preventing bone loss and fractures in patients with undiagnosed or subclinical disease. The strategy also reduces unnecessary endoscopic evaluations of healthy individuals.
The AGA recognizes individuals who have made significant contributions to gastroenterology through its esteemed recognition awards. The 2013 awardees include Dr. Chung Owyang, who received the Julius Friedenwald Medal for his lifelong contributions to the field of gastroenterology.
A new smartphone application has been shown to significantly improve colonoscopy preparation by providing personalized guidance and reminders for patients. The study found that 84% of individuals who used the app received a good score on the Boston Bowel Preparation Scale, compared to 56% of those who did not use the app.
The American Gastroenterological Association has announced the inaugural AGA Investing in the Future Student Research Fellowship Award recipients, supporting underrepresented minority students in digestive disease and nutrition research. The program aims to stimulate an interest in gastroenterological research and provide students with...
The AGA's 13th annual special issue focuses on the pancreas, presenting a variety of topics related to exocrine function, endocrine regulation, and clinical manifestations. Key findings highlight the importance of innovative treatments for patients with pancreatic diseases.
A study reports that flexible endoscopic treatment of Zenker's diverticulum using a soft diverticuloscope achieves clinical remission in the majority of cases. The technique demonstrates long-term efficacy and has a lower risk of adverse events compared to open surgery or other endoscopic stapling techniques.
Research found pregnant women with mid to high levels of anti-tTG antibodies are at risk for having reduced fetal weight and birth weight. Fetuses of women with positive anti-tTG weighed 16 grams less during the second trimester, while those with intermediate anti-tTG levels were 53 grams lighter.
A study found that patients taking tumor necrosis factor-alpha (TNF-α) antagonists are at risk of developing acute liver injury, with most cases involving autoimmunity or hepatocellular injury. The condition is typically resolved after discontinuing the drug, but some patients may experience recurrence.
Researchers identified a specific profile of patients suffering from acute-on-chronic liver failure syndrome, characterized by high mortality rates and organ malfunctions. The study provides new diagnostic criteria for the condition, which is associated with cirrhosis and can be linked to patient age and medical history.